Nevada Medicaid and Nevada Check Up News (First Quarter 2026 Provider Newsletter) [Read]

Attention Behavioral Health Providers: Monthly Behavioral Health Training Assistance (BHTA) Webinar Scheduled [See Web Announcement 2009]

Attention All Providers: Requirements on When to Use the National Provider Identifier (NPI) of an Ordering, Prescribing or Referring (OPR) Provider on Claims [Announcement 850]

If you are a Medicaid provider whose revalidation application has not been processed by your termination due date, you will be ineligible to provide services to any Nevada Medicaid or Nevada Check Up recipients, including both Fee-for-Service and Managed Care Organization (MCO) enrolled recipients. See Web Announcement 1265

Enrollment Termination Frequently Asked Questions (FAQs) [Review]

Notifications

NOTIFICATION: The following Nevada Medicaid Provider Web Portal services will be unavailable from 8 p.m. Pacific Time on Monday, May 11, 2026, through 4 a.m. Pacific Time on Tuesday, May 12, 2026, for scheduled maintenance:
  • All secure Provider Web Portal (PWP) functions
  • Provider Flex
  • Gabby®, which includes:
    • Gainwell Technologies Contact Center (877) 638-3472
    • Automated Response System (ARS) (800) 942-6511
  • Real time CAQH/CORE EDI eligibility and claim verification
  • Provider Pre-Admission Screening Resident Review (PASRR)
  • Known System Issues-Click HERE

    Top 10 Claim Denial Reasons and Resolutions/Workarounds for March 2026 Professional Claims. See Web Announcement 3894.

    Top Prior Authorization Denial Reasons for the First Quarter of 2026. See Web Announcement 3900.

    Attention Providers Using the Authorization Criteria Function: Results that return prior authorization (PA) requirements are accurate. For results that return “There are no records found based on the search criteria,” there may be a PA requirement if limits have been exceeded. To verify PA requirements, please refer to the Medicaid Services Manual (MSM) Chapter for your service type at https://NevadaMedicaid.nv.gov/ and the Billing Guide for your provider type at www.medicaid.nv.gov.

Scheduled Site Maintenance

During the scheduled site maintenance window the Provider Web Portal will be unavailable. The table below shows the regularly scheduled maintenance window. All times will be in the Pacific time zone.

Monday - Friday
12:00AM - 12:30AM

Monday
8:00PM - 12:00AM

Enhance your search:
  • Note that you can use "*" and "?" as wildcards.

  • Enclosing more than one word in double quotes ("search engine") will search for the exact phrase.
Example Zoom search template page

Search this site

Enter one or more keywords to search for using the Zoom Search Engine.
Note that '*' and '?' wildcards are supported.



Match:

Search results for: wa 0821 7001 0763 fortress pintu baja double dawar blandong mojokerto

No results found containing all search terms. 591 results found containing some search terms.

60 pages of results.
... L1851- needed. Once resolved, claims will be (Knee orthosis KO, double upright, thigh and automatically reprocessed. calf, with adjustable flexion and extension ...
Terms matched: 1  -  Score: 11  -  06 May 2026  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Known_Issues.pdf
... CARE PURCHASING AND COMPLIANCE OFFICE OF THE MEDICAID INSPECTOR GENERAL Stacie Weeks, Director 9850 Double R Blvd, Suite 200 Cynthia Leech, Administrator Joe Lombardo Reno, Nevada ...
Terms matched: 1  -  Score: 41  -  30 Apr 2026  -  URL: https://www.medicaid.nv.gov/Downloads/provider/DME_Enrollment_Moratorium_Exemption_Request.pdf
... provider website For more information about PT 93, see the following web announcements (WA): • WA 3383 • WA 3452 †...
Terms matched: 1  -  Score: 124  -  20 Feb 2025  -  URL: https://www.medicaid.nv.gov/Downloads/provider/web_announcement_3560_20250220.pdf
... patients and two confirmatory trials. The two confirmatory trials were replicate, randomized, double- blind, active controlled, parallel group trials. They evaluated 1, ...
Terms matched: 1  -  Score: 12  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Inhaled%20Anticholinergics.pdf
... prespecified secondary analysis found that the composite renal outcome (new-onset persistent macroalbumineria, persistent doubling of serum creatinine level, end-stage renal disease, and death due to renal ...
Terms matched: 1  -  Score: 12  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Incretin_Mimetics_Amylinomimetics_2018-06.pdf
... diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double- blind, placebo-controlled trials. Clin Ther. 2007;29(1 ...
Terms matched: 1  -  Score: 10  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Incretin_Mimetics_2013-1031.pdf
... diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double- blind, placebo-controlled trials. Clin Ther. 2007;29(1 ...
Terms matched: 1  -  Score: 10  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Incretin_Mimetics_2013-0812.pdf
... prespecified secondary analysis found that the composite renal outcome (new-onset persistent macroalbumineria, persistent doubling of serum creatinine level, end-stage renal disease, and death due to renal ...
Terms matched: 1  -  Score: 12  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Incretin_Mimetics%20_Amylinomimetics_2018-09.pdf
... diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double- blind, placebo-controlled trials. Clin Ther. 2007;29(1 ...
Terms matched: 1  -  Score: 10  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Incretin%20Mimetics.pdf
... (SQ) formulation of Orencia (abatacept) was based on a double-blind, double- dummy, randomized trial demonstrating noninferiority to the intravenous (IV) formulation ...
Terms matched: 1  -  Score: 46  -  28 Sep 2024  -  URL: https://www.medicaid.nv.gov/Downloads/provider/Immunomodulators_2018-0910.pdf
Result Pages: 1 2 3 4 5 6 7 8 9 10 11 Next >>

Search powered by Zoom Search Engine



Search took 0.063 seconds